Preliminary Study of Mycograb and Docetaxel in Advanced Breast Cancer

The study hypothesis is that the addition of Mycograb to docetaxel will improve outcome in advanced carcinoma of the breast.

 

Condition Intervention Phase
Cancer of the Breast Drug: Mycograb, Docetaxel Phase 1
Phase 2

 

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: A Phase Ib, Pharmacokinetic, Multiple Center, Open Label Study Evaluating the Safety and Efficacy of Mycograb Administered IV in Combination With Docetaxel in Metastatic or Recurrent Breast Cancer Patients

Antifungal name: 

Date of article/Start date of trial: 

Thursday, September 15, 2005

Trial phase: 

Phase 1

ClinicalTrials.gov ID: 

NCT00217815

Trial status: 

Completed
New antifungal drugs